Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - BIOLARGO, INC. | ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - BIOLARGO, INC. | ex32-1.htm |
| EX-21.1 - EXHIBIT 21.1 - BIOLARGO, INC. | ex21-1.htm |
| EX-31.2 - EXHIBIT 31.2 - BIOLARGO, INC. | ex31-2.htm |
| EX-4.19 - EXHIBIT 4.19 - BIOLARGO, INC. | ex4-19.htm |
| 10-K - FORM 10-K - BIOLARGO, INC. | blgo20161231_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of BioLargo, Inc. on Form S-8 (File Nos. 333-153193, 333-113443, 333-103479, 333-102226, and 333-97839) of our report dated March 30, 2017, appearing in the Annual Report on Form 10-K of BioLargo, Inc. for the year ended December 31, 2016.
Our report dated March 30, 2017 contains an explanatory paragraph that states the Company has incurred recurring losses, negative cash flows from operations and has limited capital resources, and a net stockholders’ deficit. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
|
|
/s/ HASKELL & WHITE LLP |
Irvine, California
March 30, 2017